{
    "activityid": 22498,
    "fields": {
        "Type": "Patent",
        "Title of Intellectual Property": "Preferential killing of cancer cells and activated human T-cells using the selective toxicity of zinc oxide nanoparticles. ",
        "Actual/Projected Year of Publication/Presentation": 2012,
        "Patent Nationality": "United States",
        "If Patent Cooperation Treaty, List Nations": "",
        "Copyright/Patent Number/ID": "Patent No: US 8,187,638",
        "If patent has been licensed, to whom?": "",
        "If patent has been assigned, to whom?": "",
        "Inventor(s)": null,
        "URL": null,
        "Description/Abstract": "",
        "Web Address": null,
        "Origin": "Other"
    },
    "facultyid": "111195534",
    "coauthors": {
        "78060": {
            "firstname": "Denise",
            "middleinitial": "Gay",
            "lastname": "Wingett",
            "percentcontribution": "0",
            "sameschoolflag": 1,
            "facultyid": "111195534",
            "authorid": 78060,
            "scholarlyactivityid": 22498
        },
        "78061": {
            "firstname": "Alex",
            "middleinitial": "",
            "lastname": "Punnoose",
            "percentcontribution": "0",
            "sameschoolflag": 1,
            "facultyid": "111701060",
            "authorid": 78061,
            "scholarlyactivityid": 22498
        }
    },
    "status": [
        {
            "id": 22498,
            "status": "Completed/Published",
            "term": "Spring",
            "year": 2012,
            "termid": "2011/03",
            "listingorder": 6,
            "completionorder": 6
        }
    ],
    "userid": "111195534",
    "attachments": []
}